Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026. ІХ. 2026;(3):13-26. doi:10.11603/1681-2727.2026.3.16753